Rapid, quantitative, and objective determination of the susceptibilities of human
cytomegalovirus (HCMV) clinical isolates to ganciclovir has been assessed by an assay that …

ABSTRACT A flow cytometric assay has been developed for the measurement of
susceptibilities to ganciclovir of laboratory strains and clinical isolates of human …

A rapid screening assay for the detection of resistance to ganciclovir and foscarnet of
primary isolates of human cytomegalovirus from culture-positive blood samples was …

We were able to rapidly determine the susceptibility of human cytomegalovirus to ganciclovir
using a late antigen synthesis reduction assay directly on primocultures of clinical …

Fifty-four isolates of cytomegalovirus (CMV) from 25 immunocompromised patients with
CMV infections were examined in a plaque reduction assay to determine in vitro …

Testing cytomegaloviruses for antiviral susceptibility is increasing especially since the
reports of 'resistance'to ganciclovir and foscarnet (Erice et al., 1989; Knox et al., 1991). There …

Cytomegalovirus strains with reduced in vitro susceptibilities to ganciclovir have been
recovered from patients who failed long-term ganciclovir therapy. The ganciclovir-resistant …

Susceptibility testing of 68 cytomegalovirus (CMV) peripheral blood isolates to Ganciclovir
(DHPG) and 11 blood isolates to Foscarnet (PFA), was performed on primary culture isolates …

A method for detecting the antiviral susceptibility of human cytomegalovirus (HCMV) isolates
to antiviral agents using flow cytometry was developed. This method has been used to …

There are two ways to assess the susceptibility of human cytomegalovirus (HCMV) to
ganciclovir (GCV): one is a genotypic test that detects resistance-related mutations and the …